Niklas Hammar Selected Research

Fructosamine

1/2022	Alterations in Biomarkers Related to Glycemia, Lipid Metabolism, and Inflammation up to 20 Years Before Diagnosis of Type 1 Diabetes in Adults: Findings From the AMORIS Cohort.
1/2021	Blood-Based Biomarkers and Long-term Risk of Frailty-Experience From the Swedish AMORIS Cohort.
1/2014	Fructosamine is a useful indicator of hyperglycaemia and glucose control in clinical and epidemiological studies--cross-sectional and longitudinal experience from the AMORIS cohort.
1/2013	Serum glucose and fructosamine in relation to risk of cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Niklas Hammar Research Topics

Disease

24	Type 2 Diabetes Mellitus (MODY) 03/2022 - 06/2004
24	Neoplasms (Cancer) 11/2021 - 10/2010
16	Myocardial Infarction 12/2021 - 09/2006
13	Inflammation (Inflammations) 01/2022 - 11/2010
12	Prostatic Neoplasms (Prostate Cancer) 06/2019 - 05/2011
11	Heart Failure 11/2021 - 08/2006
9	Stroke (Strokes) 12/2021 - 08/2006
9	Breast Neoplasms (Breast Cancer) 01/2021 - 08/2011
8	Cardiovascular Diseases (Cardiovascular Disease) 12/2021 - 01/2006
6	Obesity 01/2018 - 09/2003
4	Dementia (Dementias) 01/2022 - 01/2020
4	Diabetes Mellitus 01/2020 - 09/2006
4	Hypertension (High Blood Pressure) 01/2018 - 08/2002
4	Ischemic Stroke 03/2016 - 08/2006
3	Infections 01/2021 - 09/2003
3	Chronic Renal Insufficiency 01/2021 - 09/2011
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020 - 09/2011
3	Ovarian Neoplasms (Ovarian Cancer) 01/2019 - 08/2011
3	Carcinogenesis 01/2019 - 09/2011
3	Melanoma (Melanoma, Malignant) 01/2019 - 06/2016
2	Prediabetic State (Prediabetes) 11/2021 - 09/2009
2	Atrial Fibrillation 11/2021 - 08/2006
2	Fibrosis (Cirrhosis) 06/2021 - 01/2017
2	Frailty 01/2021 - 01/2012
2	Anemia 01/2021 - 08/2012
2	Parkinson Disease (Parkinson's Disease) 12/2019 - 01/2019
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 12/2019 - 05/2017
2	Body Weight (Weight, Body) 01/2018 - 02/2008
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018 - 01/2017
2	Colorectal Neoplasms (Colorectal Cancer) 05/2017 - 07/2013
2	Acute Kidney Injury (Acute Renal Failure) 03/2014 - 04/2012
2	Rectal Neoplasms (Rectal Cancer) 07/2013 - 01/2012
2	Colonic Neoplasms (Colon Cancer) 07/2013 - 01/2012
2	Endometrial Neoplasms (Endometrial Cancer) 01/2012 - 08/2011
2	Coronary Stenosis (Coronary Artery Stenosis) 10/2008 - 08/2006
2	Pathologic Constriction (Stenosis) 10/2008 - 08/2006
2	Renal Insufficiency (Renal Failure) 04/2007 - 09/2005
2	Atherosclerosis 09/2003 - 04/2003
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022
1	Cognitive Dysfunction 12/2021
1	Aortic Valve Stenosis (Aortic Stenosis) 07/2021
1	Aortic Valve Disease 07/2021
1	Non-alcoholic Fatty Liver Disease 06/2021
1	Hepatocellular Carcinoma (Hepatoma) 06/2021
1	Liver Cirrhosis (Hepatic Cirrhosis) 06/2021
1	Liver Diseases (Liver Disease) 06/2021
1	Chronic Hepatitis C 06/2021

Drug/Important Bio-Agent (IBA)

44	Glucose (Dextrose)FDA LinkGeneric 03/2022 - 09/2009
26	ApolipoproteinsIBA 01/2022 - 01/2009
19	LipidsIBA 01/2022 - 08/2002
17	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2012
10	CholesterolIBA 02/2019 - 04/2003
9	Triglycerides (Triacylglycerol)IBA 01/2022 - 05/2011
9	AlbuminsIBA 01/2021 - 07/2013
8	SodiumIBA 01/2022 - 03/2017
8	Apolipoproteins B (ApoB)IBA 01/2022 - 11/2010
7	Immunoglobulin G (IgG)IBA 01/2021 - 09/2003
7	C-Reactive ProteinIBA 01/2021 - 09/2003
7	HaptoglobinsIBA 01/2021 - 01/2009
6	Immunoglobulin A (IgA)IBA 01/2021 - 09/2003
5	Metformin (Glucophage)FDA LinkGeneric 01/2022 - 01/2018
5	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2022 - 11/2010
5	Immunoglobulin M (IgM)IBA 01/2021 - 01/2019
4	FructosamineIBA 01/2022 - 01/2013
4	Pharmaceutical PreparationsIBA 01/2022 - 01/2018
4	Apolipoproteins AIBA 12/2021 - 05/2012
4	Lipoproteins (Lipoprotein)IBA 07/2021 - 11/2009
4	Immunoglobulins (Immunoglobulin)IBA 01/2021 - 01/2019
4	IronIBA 01/2021 - 07/2013
4	CalciumIBA 09/2016 - 08/2012
3	Insulin (Novolin)FDA Link 01/2022 - 09/2006
3	Uric Acid (Urate)IBA 01/2022 - 06/2017
3	Hypoglycemic Agents (Hypoglycemics)IBA 12/2021 - 11/2017
3	omega-Chloroacetophenone (Mace)IBA 07/2021 - 11/2010
3	Sodium-Glucose Transport ProteinsIBA 01/2019 - 07/2017
3	HDL CholesterolIBA 01/2019 - 08/2002
2	AntigensIBA 01/2020 - 01/2019
2	oxidized low density lipoproteinIBA 01/2019 - 01/2017
2	dapagliflozinIBA 01/2019 - 03/2017
2	empagliflozinIBA 01/2019 - 07/2017
2	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2019 - 01/2018
2	TransferasesIBA 01/2018 - 01/2017
2	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2018 - 01/2018
2	Immunoglobulin E (IgE)IBA 06/2016 - 10/2010
2	CreatinineIBA 03/2014 - 09/2005
2	Indicators and Reagents (Reagents)IBA 12/2012 - 09/2011
2	Warfarin (Coumadin)FDA LinkGeneric 04/2010 - 08/2006
2	Coffee FDA Link 03/2009 - 06/2004
1	Alkaline PhosphataseIBA 01/2022
1	glucagon-like peptide 1 (7-36)amideIBA 01/2022
1	AutoantibodiesIBA 01/2022
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2022
1	BilirubinIBA 11/2021
1	AntioxidantsIBA 11/2021
1	Alanine Transaminase (SGPT)IBA 06/2021
1	Transaminases (Aminotransferases)IBA 06/2021
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 06/2021
1	Aspartic Acid (Aspartate)FDA Link 06/2021

Therapy/Procedure

18	Therapeutics 03/2022 - 01/2015
10	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 03/2014 - 09/2003